The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases.

Autor: Genovese F; Nordic Bioscience A/S, Herlev, Denmark. Electronic address: fge@nordicbio.com., Bager C; Nordic Bioscience A/S, Herlev, Denmark., Frederiksen P; Nordic Bioscience A/S, Herlev, Denmark., Vazquez D; Nordic Bioscience A/S, Herlev, Denmark., Sand JMB; Nordic Bioscience A/S, Herlev, Denmark., Jenkins RG; Imperial College London 4615, National Heart & Lung Institute, London, UK., Maher TM; Keck Medicine of University of Southern California, 1510 San Pablo Street, Los Angeles, CA 90033, USA., Stewart ID; Imperial College London 4615, National Heart & Lung Institute, London, UK., Molyneaux PL; Imperial College London 4615, National Heart & Lung Institute, London, UK., Fahy WA; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK., Wain LV; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK; Department of Population Health Sciences, University of Leicester, Leicester, UK., Vestbo J; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, England., Nanthakumar C; Clinical Sciences (Respiratory), GSK Research & Development, GSKH, Brentford, UK., Shaker SB; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Hovedstaden, Denmark., Hoyer N; Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Hovedstaden, Denmark., Leeming DJ; Nordic Bioscience A/S, Herlev, Denmark., George J; Storr Liver Centre, The Westmead Institute for Medical Research and Westmead Hospital, University of Sydney, Sydney, NSW, Australia., Trebicka J; Medizinische Klinik B, Universitätsklinikum Münster, Münster University, Münster, Germany., Rasmussen DGK; Nordic Bioscience A/S, Herlev, Denmark., Hansen MK; Janssen Research & Development, LLC, Spring House, PA, USA., Cockwell P; Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Kremer D; Department of Internal Medicine, University Medical Center Groningen, University of Groningen 9713 GZ, Groningen, The Netherlands., Bakker SJ; Department of Internal Medicine, University Medical Center Groningen, University of Groningen 9713 GZ, Groningen, The Netherlands., Selby NM; Department of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK., Reese-Petersen AL; Nordic Bioscience A/S, Herlev, Denmark., González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA 31008, Pamplona, Spain; Centro de investigacion biomedica en red enfermedades cardiovasculares, Madrid, Spain., Núñez J; Department of Cardiology, Hospital Clínico Universitario de Valencia (INCLIVA), Valencia, Spain., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Nissen NI; Nordic Bioscience A/S, Herlev, Denmark., Boisen MK; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Chen IM; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Zhao L; Bristol-Myers Squibb Company, Lawrenceville, New Jersey, USA., Karsdal MA; Nordic Bioscience A/S, Herlev, Denmark., Schuppan D; Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Mainz, Germany.

Publikováno v: Matrix biology : journal of the International Society for Matrix Biology [Matrix Biol] 2024 Sep; Vol. 132, pp. 1-9. Date of Electronic Publication: 2024 Jun 11.

Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy.

Autor: Johansen AZ; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Novitski SI; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Hjaltelin JX; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Theile S; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Boisen MK; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Madsen DH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.; Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Nielsen DL; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Chen IM; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Sep 07; Vol. 14, pp. 1228907. Date of Electronic Publication: 2023 Sep 07 (Print Publication: 2023).

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Autor: Høgdall D; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: Danhog01@regionh.dk., O'Rourke CJ; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Denmark., Larsen FO; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Zarforoushan S; Department of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Christensen TD; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Ghazal A; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Denmark., Boisen MK; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark., Muñoz-Garrido P; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Denmark., Johansen JS; Department of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Medicine, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, Department of Health and Medical Sciences, University of Copenhagen, Denmark., Andersen JB; Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: jesper.andersen@bric.ku.dk.

Publikováno v: Journal of hepatology [J Hepatol] 2022 Oct; Vol. 77 (4), pp. 1047-1058. Date of Electronic Publication: 2022 Jun 21.

Behavioral factors associated with SARS-CoV-2 infection.

Autor: Cajar MD; Department of Oncology and Palliative Medicine, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark.; Department of Cardiology, Nordsjaellands Hospital, University of Copenhagen, Hillerod, Denmark., Tan FCC; Department of Oncology and Palliative Medicine, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark., Boisen MK; Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Krog SM; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Nolsoee R; Department of Endocrinology, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark., Collatz Christensen H; Department of Emergency Medical Services, University of Copenhagen, Copenhagen, Denmark., Andersen MP; Department of Clinical Research, Nordsjaellands Hospital, Hillerod, Denmark., Moeller AL; Department of Cardiology, Nordsjaellands Hospital, University of Copenhagen, Hillerod, Denmark., Gerds TA; Department of Biostatistics, University of Copenhagen, Copenhagen, UK., Pedersen-Bjergaard U; Department of Endocrinology and Nephrology, Nordsjaellands Hospital, University of Copenhagen, Hillerod, Denmark.; Faculty of Health Sciences, University of Copenhagen, Kobenhavn, Denmark., Lindegaard B; Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark., Kristensen PL; Department of Endocrinology and Nephrology, Nordsjaellands Hospital, University of Copenhagen, Hillerod, Denmark., Christensen TB; Department of Oncology and Palliative Medicine, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark., Torp-Pedersen C; Department of Cardiology, Nordsjaellands Hospital, University of Copenhagen, Hillerod, Denmark., Lendorf ME; Department of Oncology and Palliative Medicine, Nordsjællands Hospital, University of Copenhagen, Hillerod, Denmark maria.lendorf@dadlnet.dk.

Publikováno v: BMJ open [BMJ Open] 2022 Jun 03; Vol. 12 (6), pp. e056393. Date of Electronic Publication: 2022 Jun 03.

Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer.

Autor: Lehtomäki K; Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.; Department of Oncology: Tays Cancer Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland., Mustonen H; Department of Gastrointestinal Surgery, Helsinki University Hospital and University of Helsinki, P.O. Box 440, 00029 HUS Helsinki, Finland.; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, P.O. Box 4, 00014 Helsinki, Finland., Kellokumpu-Lehtinen PL; Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.; Department of Oncology: Tays Cancer Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland., Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland., Hermunen K; Department of Gastrointestinal Surgery, Helsinki University Hospital and University of Helsinki, P.O. Box 440, 00029 HUS Helsinki, Finland., Soveri LM; Hyvinkää Hospital and Hyvinkää Homecare, Sairaalankatu 1, 05850 Hyvinkää, Finland., Boisen MK; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls vej 1, DK-2730 Herlev, Denmark., Dehlendorff C; Statistics and Data Analysis Danish Cancer Society Research Center, Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen, Denmark., Johansen JS; Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Borgmester Ib Juuls vej 1, DK-2730 Herlev, Denmark.; Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital and University of Copenhagen, Borgmester Ib Juuls vej 1, DK-2730 Herlev, Denmark.; Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark., Haglund C; Department of Gastrointestinal Surgery, Helsinki University Hospital and University of Helsinki, P.O. Box 440, 00029 HUS Helsinki, Finland.; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, P.O. Box 4, 00014 Helsinki, Finland., Osterlund P; Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.; Department of Oncology: Tays Cancer Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland.; Department of Oncology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland.; Department of Oncology-Pathology, Karolinska Institutet, Karolinska vägen A2:07, 171 64 Stockholm, Sweden.; Tema Cancer-Bäckensektionen, Karolinska sjukhuset, Eugeniavägen 3, 171 64 Stockholm, Sweden.

Publikováno v: Cancers [Cancers (Basel)] 2021 Aug 02; Vol. 13 (15). Date of Electronic Publication: 2021 Aug 02.